Use of icos-based cars to enhance antitumor activity and car persistence

作者: Carl H. June , John Scholler , Sonia Guedan Carrio , Yangbing Zhao

DOI:

关键词: Cell biologyGenetically modified organismTransmembrane domainAntitumor activityAntigen bindingIntracellularDomain (software engineering)ChemistryImmunologyCell

摘要: The present invention provides compositions and methods for treating cancer in a human. includes administering genetically modified Thl7 cell to express CAR having an antigen binding domain, transmembrane ICOS intracellular signaling domain.

参考文章(71)
Ed Harlow, David Lane, Using Antibodies: A Laboratory Manual ,(1998)
Minuth Wilhelm, Apparatus for cultivating cells ,(1990)
Ruxandra Draghia-Akli, Heather Attra, Douglas R. Kern, Henry Hebel, Robert H. Carpenter, Leigh Anne Hill, Increased delivery of a nucleic acid constrtuct in vivo by the poly-l-glutamate (plg) system ,(2003)
Carl H. June, Marcela Maus, James L. Riley, Anna Thomas, Robert Vonderheide, Activation and Expansion of T-Cells Using An Engineered Multivalent Signaling Platform as a Research Tool ,(2010)
Jeffrey I. Levatter, Steven C. Dimmer, Sukhendu B. Dev, Gunter A. Hofmann, Gurvinder S. Nanda, Minimally invasive apparatus and method to electroporate drugs and genes into tissue ,(1998)
Nicole Aqui, Carl H. June, Megan M. Suhoski, James L. Riley, Robert H. Vonderheide, Novel artificial antigen presenting cells and uses therefor ,(2005)
Dietmar P. Rabussay, Gunter A. Hofmann, Lei Zhang, Intradermal delivery of active agents by needle-free injection and electroporation ,(2003)
Michel Sadelain, John Maher, Renier Brentjens, Chimeric T cell receotors ,(2003)